Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AVEO PHARMA (NQ: AVEO)
2.620 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about AVEO PHARMA
 
< Previous 1 2 3 4 5 Next >
Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
June 17, 2013
from Business Wire News Releases
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO
June 14, 2013
from GlobeNewswire News Releases
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
June 12, 2013
from Business Wire News Releases
AVEO Announces Complete Response Letter Received for Tivozanib New Drug Application in Renal Cell Carcinoma
June 10, 2013
from Business Wire News Releases
AVEO Oncology Announces Strategic Restructuring
June 04, 2013
from Business Wire News Releases
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc.
May 31, 2013
from Business Wire News Releases
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against AVEO Pharmaceuticals, Inc.
May 31, 2013
from Business Wire News Releases
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO
May 31, 2013
from GlobeNewswire News Releases
Free Research Reports on AVEO, IOC, MRVL and P Issued by the Bedford Report
May 28, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
May 22, 2013
from PR Newswire
Law Offices of Todd M. Garber Announces Investigation of AVEO Pharmaceuticals, Inc.
May 20, 2013
from Business Wire News Releases
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
May 18, 2013
from PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO
May 17, 2013
from GlobeNewswire News Releases
Aveo Pharmaceuticals, Inc. Sued by Investor
May 17, 2013
from PR Newswire
AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting
May 15, 2013
from Business Wire News Releases
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
May 14, 2013
from Business Wire News Releases
The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
May 14, 2013
from PR Newswire
Abraham, Fruchter & Twersky, LLP Announces That a Class Action Lawsuit Has Been Filed against AVEO Pharmaceuticals, Inc.
May 14, 2013
from Business Wire News Releases
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in AVEO Pharmaceuticals, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff
May 13, 2013
from GlobeNewswire News Releases
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)
May 12, 2013
from Marketwired News Releases
Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
May 10, 2013
from PR Newswire
Pomerantz Law Firm has filed a Class Action Against Aveo Pharmaceuticals, Inc. and Certain Officers -- AVEO
May 09, 2013
from GlobeNewswire News Releases
The Real Story Behind WIN, FITB, ZAGG and AVEO
May 04, 2013
from Marketwired News Releases
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aveo Pharmaceuticals, Inc.
May 03, 2013
from PR Newswire
Free Research Reports on AVEO, CXO, MWW and VRTX Issued by the Paragon Report
May 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Squawk Box Stocks Reports on: Facebook Inc. (NASDAQ: FB), Yelp, Inc. (NYSE: YELP), LinkedIn Corporation (NYSE: LNKD), AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)
May 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of AVEO Pharmaceuticals, Inc.
May 02, 2013
from Business Wire News Releases
AVEO and Astellas Report FDA Oncologic Drug Advisory Committee Votes Tivozanib Application Did Not Demonstrate Favorable Benefit-to-Risk Evaluation in Treatment of Advanced Renal Cell Carcinoma
May 02, 2013
from Business Wire News Releases
Trading of AVEO Common Stock Halted
May 02, 2013
from Business Wire News Releases
Today's Stocks in Focus: (NASDAQ: AVEO), (NASDAQ: FTNT)
May 01, 2013
from SBWire Direct - Latest Press Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here